Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.48%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.38%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.15%ABBV+0.94%ASMLa-9.33%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%1816.HK+3.45%HD+0.70%3988.HK-1.13%BAC-3.15%GE-2.90%0857.HK-0.49%ORCL-8.49%UNH+2.84%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L-3.62%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.69%ORp-0.36%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.62%ETHUSD+77.41%USDTUSD+0.11%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.22%ZECUSDT+4.58%XMRUSDT+7.51%DOGEUSD+72.43%LINKUSD+1.11%XLMUSD+1.88%BCHUSDT+2.52%LTCUSD+64.72%UNIUSD+5.47%TONUSD+74.91%SUIUSD-0.60%HBARUSDT+0.39%TAOUSDT+2.81%AAVEUSD-0.47%ONDOUSDT-0.45%DOTUSDT-2.05%ICPUSDT-6.44%WLDUSDT-0.52%ARBUSDT-1.08%ATOMUSDT-4.00%INJUSDT-4.62%STXUSDT+2.91%PYTHUSDT+0.51%TIAUSDT-1.31%FETUSDT-3.51%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.44%OPUSDT+0.63%IOTAUSDT-1.74%POLUSDT-0.14%WIFUSDT-2.78%AXSUSDT+0.75%EOSUSDT+0.62%IMXUSDT-3.33%FARTCOINUSDT-0.27%GALAUSDT-2.18%DYDXUSDT-3.92%ORDIUSDT-0.39%NOTUSDT-1.52%RONINUSDT+0.62%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.48%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.38%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.15%ABBV+0.94%ASMLa-9.33%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%1816.HK+3.45%HD+0.70%3988.HK-1.13%BAC-3.15%GE-2.90%0857.HK-0.49%ORCL-8.49%UNH+2.84%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L-3.62%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.69%ORp-0.36%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%CHFJPY0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%EURPLN0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+2.62%ETHUSD+77.41%USDTUSD+0.11%XRPUSD+64.83%SOLUSD+72.04%TRXUSDT+1.22%ZECUSDT+4.58%XMRUSDT+7.51%DOGEUSD+72.43%LINKUSD+1.11%XLMUSD+1.88%BCHUSDT+2.52%LTCUSD+64.72%UNIUSD+5.47%TONUSD+74.91%SUIUSD-0.60%HBARUSDT+0.39%TAOUSDT+2.81%AAVEUSD-0.47%ONDOUSDT-0.45%DOTUSDT-2.05%ICPUSDT-6.44%WLDUSDT-0.52%ARBUSDT-1.08%ATOMUSDT-4.00%INJUSDT-4.62%STXUSDT+2.91%PYTHUSDT+0.51%TIAUSDT-1.31%FETUSDT-3.51%SEIUSDT-1.94%JUPUSDT-4.27%GRTUSDT+0.44%OPUSDT+0.63%IOTAUSDT-1.74%POLUSDT-0.14%WIFUSDT-2.78%AXSUSDT+0.75%EOSUSDT+0.62%IMXUSDT-3.33%FARTCOINUSDT-0.27%GALAUSDT-2.18%DYDXUSDT-3.92%ORDIUSDT-0.39%NOTUSDT-1.52%RONINUSDT+0.62%
NA

Natera, Inc. (NTRA)

NASDAQ • Healthcare

$273.39
-$16.52 (-5.7%)
Market closed

Last close at November 20, 2026 at 21:00 UTC

Open$286.69
Day Range$271.85 - $288.4
Avg. Volume (3M)2.2M
Market Cap$39.6B
52 Week Range
$181$437.41

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$793.9M100%
Gross Profitminus cost of goods$513.4M65%

In plain terms: out of every $100 in revenue, Natera, Inc. currently loses $8.

Fundamentals & Financials

Revenue (TTM)
$2.9B
Net Income (TTM)
-$164.7M
EPS (TTM)
-$1.14
ROA (TTM)
-5.99%
Current Ratio
2.81

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-3.3%Q2 2026-$0.56
+4.8%Q3 2026-$0.47
-49.5%Q4 2026-$0.42

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Miss -49.5%

Natera’s preliminary third fiscal quarter of 2026 results paired a revenue beat with an EPS miss, as revenue of $794.0 million topped the $707.5 million estimate, +12.2%, while EPS of -$0.42 trailed the -$0.28 estimate by -$0.14, with the company reporting on November 5, 2026. Revenue rose ~34% to about $794.0 million (up from roughly $592.2 million a year ago), led by Insurance carriers, which increased ~36% to about $705.1 million, while Laboratory partners grew roughly 70% to about $37.7 million. Profitability tracked with a gross margin of roughly 65% and an operating margin of -8.6%, as operating income was -$68.3 million. Net income improved ~32% year over year to about -$59.9 million (from roughly -$87.5 million), and EPS improved ~34% from -$0.64 a year ago to -$0.42. The quarter generated operating cash flow of about $43.9 million. For the next period, consensus calls for EPS of -$0.11 on revenue of $749.5 million.

View full earnings history

About Natera, Inc.

Natera, Inc. (NASDAQ: NTRA) develops genetic testing and molecular monitoring products for healthcare, operating in diagnostics and research, with $2.3 billion in revenue in FY2025. Its menu spans reproductive health, oncology, and transplant testing, pairing laboratory-developed assays with direct sales and partner distribution on a global basis.

Name
Natera, Inc.
CEO
Solomon Moshkevich
Industry
Healthcare
Year Founded
2003
Employees
6,138

Today's Snapshot

AI-generated

The day ended with NTRA 5.7% lower at 273.40, while its sector was flat. Trading was lighter than usual, with volume about two-thirds of its usual level. Natera’s management targeted more than $6 billion by 2029.

Trading Volume

Below 10d avg (2.0M)

1.3M

vs S&P 500 Today

Underperforming Market

-2.21%

Updated: November 20, 2026 at 21:23 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
NTRA shows a strong sell stance as multiple momentum measures and trend indicators align bearish despite oversold oscillators. ADX above 40 signals a strong directional move, and MACD is deeply negative while momentum confirms the downside; RSI and stochastic are oversold but have not mitigated selling pressure. The current price is below most short- and medium-term averages and the classic pivot sits above the market, with ATR elevated and OBV negative, signaling volatile declines on falling volume. Technical takeaway: Strong Sell — strong trend and momentum favor the downside despite oversold readings.
All signals
  • EMA (5 indicators)$291.25 - $350.42
    Sell
  • RSI (14)26.15
    Buy
  • Stochastic %K (14, 3, 3)6.06
    Buy
  • MACD Level (12, 26)-28.90
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.